Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Rong

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Pharmaceutical Statistics|September 27, 2022
An adaptive biomarker basket design in phase II oncology trialsShufang Liu, Kentaro Takeda, Alan Rong
Statistics in Medicine|October 26, 2021
Constrained hierarchical Bayesian model for latent subgroups in basket trials with two classifiersKentaro Takeda, Shufang Liu, Alan Rong
Therapeutic Innovation & Regulatory Science|April 22, 2023
Comparison Between Simultaneous and Sequential Utilization of Safety and Efficacy for Optimal Dose Determination in Bayesian Model-Assisted DesignsRan Li, Kentaro Takeda, Alan Rong
Pharmaceutical Statistics|July 31, 2018
Weighted log-rank test for time-to-event data in immunotherapy trials with random delayed treatment effect and cure rateShufang Liu, Chenghao Chu, Alan Rong
Pharmaceutical Statistics|January 14, 2020
Study design of single-arm phase II immunotherapy trials with long-term survivors and random delayed treatment effectChenghao Chu, Shufang Liu, Alan Rong
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2013
Evaluation of progression-free survival as a surrogate endpoint for survival in chemotherapy and targeted agent metastatic colorectal cancer trialsRoger Sidhu, Alan Rong, Steve Dahlberg
Journal of Biopharmaceutical Statistics|February 19, 2024
A basket trial design based on constrained hierarchical Bayesian model for latent subgroupsKentaro Takeda, Atsuki Hashimoto, Shufang Liu, et al.
Journal of Biopharmaceutical Statistics|October 26, 2018
Estimation of delay time in survival data with delayed treatment effectWei Li, Sophie Yu-Pu Chen, Alan Rong
Pharmaceutical Statistics|December 4, 2021
TITE-gBOIN: Time-to-event Bayesian optimal interval design to accelerate dose-finding accounting for toxicity gradesKentaro Takeda, Qing Xia, Shufang Liu, et al.
BMC Medical Research Methodology|November 2, 2015
Flexible combination of multiple diagnostic biomarkers to improve diagnostic accuracyTu Xu, Yixin Fang, Alan Rong, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Pharmaceutical Statistics|September 27, 2022
An adaptive biomarker basket design in phase II oncology trialsShufang Liu, Kentaro Takeda, Alan Rong
Statistics in Medicine|October 26, 2021
Constrained hierarchical Bayesian model for latent subgroups in basket trials with two classifiersKentaro Takeda, Shufang Liu, Alan Rong
Therapeutic Innovation & Regulatory Science|April 22, 2023
Comparison Between Simultaneous and Sequential Utilization of Safety and Efficacy for Optimal Dose Determination in Bayesian Model-Assisted DesignsRan Li, Kentaro Takeda, Alan Rong
Pharmaceutical Statistics|July 31, 2018
Weighted log-rank test for time-to-event data in immunotherapy trials with random delayed treatment effect and cure rateShufang Liu, Chenghao Chu, Alan Rong
Pharmaceutical Statistics|January 14, 2020
Study design of single-arm phase II immunotherapy trials with long-term survivors and random delayed treatment effectChenghao Chu, Shufang Liu, Alan Rong
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2013
Evaluation of progression-free survival as a surrogate endpoint for survival in chemotherapy and targeted agent metastatic colorectal cancer trialsRoger Sidhu, Alan Rong, Steve Dahlberg
Journal of Biopharmaceutical Statistics|February 19, 2024
A basket trial design based on constrained hierarchical Bayesian model for latent subgroupsKentaro Takeda, Atsuki Hashimoto, Shufang Liu, et al.
Journal of Biopharmaceutical Statistics|October 26, 2018
Estimation of delay time in survival data with delayed treatment effectWei Li, Sophie Yu-Pu Chen, Alan Rong
Pharmaceutical Statistics|December 4, 2021
TITE-gBOIN: Time-to-event Bayesian optimal interval design to accelerate dose-finding accounting for toxicity gradesKentaro Takeda, Qing Xia, Shufang Liu, et al.
BMC Medical Research Methodology|November 2, 2015
Flexible combination of multiple diagnostic biomarkers to improve diagnostic accuracyTu Xu, Yixin Fang, Alan Rong, et al.
Pageof 2